84
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Statistical modeling methods to analyze the impacts of multiunit process variability on critical quality attributes of Chinese herbal medicine tablets

, , , , , , & show all
Pages 3909-3924 | Published online: 28 Nov 2016

References

  • YuanRLinYTraditional Chinese medicine: an approach to scientific proof and clinical validationPharmacol Ther200086219119810799714
  • YuKWangYWChengYYDetermination of paeonol and paeoniflorin in Chinese medicine Cortex Moutan and ‘Shuangdan’granule by micellar electrokinetic capillary chromatographyJ Pharm Biomed Anal20064051257126216253465
  • LiXDNieSFWuLJStudies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound RecipeJ Control Release200496335936715120893
  • ZhaoXZhangYMengXEffect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography–mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20088732151158
  • LiebermanHHLachmanLSchwartzJBPharmaceutical dosage forms: tabletsNew YorkMarcel Dekker1989
  • Chinese Pharmacopoeia CommissionChinese Pharmacopoeia9th edBeijing, ChinaChemical Industry Press2015I
  • FengHChenWZhuCPharmacokinetics study of bio-adhesive tablet of Panax notoginseng saponinsInt Arch Med2011411821658246
  • ICH Expert Working GroupInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline; Pharmaceutical Development; Q8 GuidelineGeneva, Switzerland2009 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf/Accessed November 17, 2016
  • TombaEFaccoPBezzoFBaroloMLatent variable modeling to assist the implementation of quality-by-design paradigms in pharmaceutical development and manufacturing: a reviewInt J Pharm2013457128329724016743
  • LawrenceXYPharmaceutical quality by design: product and process development, understanding, and controlPharm Res200825478179118185986
  • HamadMLBowmanKSmithNShengXMorrisKRMulti-scale pharmaceutical process understanding: from particle to powder to dosage formChem Eng Sci2010652156255638
  • KatherineABProcess analytical technology: spectroscopic tools and implementation strategies for the chemical and pharmaceutical industriesOxfordBlackwell Publishing Ltd2005
  • De BeerTBurggraeveAFonteyneMSaerensLRemonJPVervaetCNear infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processesInt J Pharm20114171324721167266
  • WuHWhiteMKhanMAQuality-by-design (QbD): an integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space developmentInt J Pharm20114051637821138762
  • De BeerTWiggenhornMHaweAOptimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzersTalanta20118351623163321238761
  • BoukouvalaFMuzzioFJIerapetritouMGDesign space of pharmaceutical processes using data-driven-based methodsJ Pharma Innova201053119137
  • GernaeyKVGaniRA model-based systems approach to pharmaceutical product-process design and analysisChem Eng Sci2010652157575769
  • ManagerGSStatistical experimental design and its application to pharmaceutical development problemsDrug Dev Ind Pharm1986128–911091123
  • HawareRVThoIBauer-BrandlAMultivariate analysis of relationships between material properties, process parameters and tablet tensile strength for α-lactose monohydratesEur J Pharm Biopharm200973342443119698784
  • SohJLPWangFBoersenNUtility of multivariate analysis in modeling the effects of raw material properties and operating parameters on granule and ribbon properties prepared in roller compactionDrug Dev Ind Pharm200834101022103518777445
  • MaltesenMJBjerregaardSHovgaardLHavelundSVan de WeertMQuality by design–Spray drying of insulin intended for inhalationEur J Pharm Biopharm200870382883818755270
  • PolizziMAGarcía-MuñozSA framework for in-silico formulation design using multivariate latent variable regression methodsInt J Pharm2011418223524221569826
  • WesterhuisJACoenegrachtPMJMultivariate modelling of the pharmaceutical two-step process of wet granulation and tableting with multiblock partial least squaresJ Chemometr1997115379392
  • MacGregorJFJaeckleCKiparissidesCKoutoudiMProcess monitoring and diagnosis by multiblock PLS methodsAIChE J1994405826838
  • TombaEDe MartinMFaccoPGeneral procedure to aid the development of continuous pharmaceutical processes using multivariate statistical modeling – an industrial case studyInt J Pharm20134441253923337630
  • DumareyMWikströmHFranssonMCombining experimental design and orthogonal projections to latent structures to study the influence of microcrystalline cellulose properties on roll compactionInt J Pharm2011416111011921708239
  • TryggJWoldSOrthogonal projections to latent structures (O-PLS)J Chemometr2002163119128
  • TryggJPrediction and spectral profile estimation in multivariate calibrationJ Chemometr2004183–4166172
  • KourtiTProcess analytical technology beyond real-time analyzers: the role of multivariate analysisCrit Rev Anal Chem2006363–4257278
  • KourtiTQbD-quality by design in the pharmaceutical industry: the role of multivariate analysisAm Pharm Rev2009124118
  • KourtiTPharmaceutical manufacturing: the role of multivariate analysis in design space, control strategy, process understanding, troubleshooting, and optimizationam EndeDJChemical Engineering in the Pharmaceutical Industry: R&D to ManufacturingHoboken, NJJohn Wiley & Sons, Inc2010
  • VermaSLanYGokhaleRBurgessDJQuality by design approach to understand the process of nanosupsension preparationInt J Pharm2009377118519819446617
  • NoriokaTKikuchiSOnukiYTakayamaKImaiKOptimization of the manufacturing process for oral formulations using multivariate statistical methodsJ Pharm Innov201163157169
  • SouihiNDumareyMWikstromHA quality by design approach to investigate the effect of mannitol and dicalcium phosphate qualities on roll compactionInt J Pharm20134471476123434544
  • Pharmacopeia of USAUSP Chapter 616: Bulk Density and Tapped DensityRockville, MDUSP2012255258
  • FellJTNewtonJMDetermination of tablet strength by the diametral-compression testJ Pharm Sci19705956886915446428
  • Pharmacopeia of USAUSP Chapter 711: DissolutionRockville, MDUSP2012295301
  • DaiSXuBZhangYRobust design space development for HPLC analysis of five chemical components in Panax notoginseng saponinsJ Liq Chromatogr R T20163910504512
  • DumareyMGoodwinDJDavisonCMultivariate modelling to study the effect of the manufacturing process on the complete tablet dissolution profileInt J Pharm2015486111212025797055
  • ChongIGJunCHPerformance of some variable selection methods when multi-collinearity is presentChemometr Intell Lab2005781103112
  • LiuZBruwerMJMacGregorJFRathoreSSSReedDEChampagneMJModeling and optimization of a tablet manufacturing lineJ Pharm Innova201163170180